Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection-Reference-Cited by-同舟云学术

Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection

Published:1992-06 Issue:6 Volume:22 Page:1483-1494
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Dunne David W.,Butterworth Anthony E.,Fulford Anthony J. C.,Curtis Kariuki H.,Langley Jane G.,Ouma John H.,Capron Andre,Pierce Raymond J.,Sturrock Robert F.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment

2. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses

3. Longitudinal studies on human schistosomiasis

4. Resistance to reinfection after treatment of urinary schistosomiasis

5. Immunity after treatment of human schistosomiasis mansoni. III. Long-term effects of treatment and retreatment

Cited by 361 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergence of Sh 22.6 kDa Antigen Among the Schistosoma haematobium Infected People in Riverine Communities of the Extreme North Western Nigeria;2024-08-30

2. Protective human IgE responses are promoted by comparable life-cycle dependent Tegument Allergen-Like expression in Schistosoma haematobium and Schistosoma mansoni infection;PLOS Pathogens;2023-05-25

3. Anti-schistosomal immunity to core xylose/fucose in N-glycans;Frontiers in Molecular Biosciences;2023-04-04

4. Protective human IgE responses are promoted by comparable life-cycle dependent Tegument Allergen-Like protein expression inSchistosoma haematobiumandSchistosoma mansoniinfection;2022-12-05

5. Identification of major human IgE-inducing parasite antigens: A path to therapeutic approaches?;Journal of Allergy and Clinical Immunology;2022-12